Related Experiment Videos
ASE-1: an autoantigen in systemic lupus erythematosus
S Edworthy1, M Fritzler, C Whitehead
1Department of Anatomy and Cell Biology University of Calgary, Calgary, Alberta, Canada.
Lupus
|February 24, 2001
Summary
Autoantibodies to ASE-1 are more frequent in systemic lupus erythematosus (SLE) patients and correlate with serositis, suggesting ASE-1 is an important serological marker for SLE.
Area of Science:
- Immunology
- Rheumatology
- Autoimmunity
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- Identifying specific autoantigens is crucial for accurate diagnosis and understanding disease mechanisms.
Purpose of the Study:
- To investigate the diagnostic significance of autoantibodies to the nucleolar autoantigen ASE-1 in SLE.
- To determine the association of ASE-1 autoantibodies with clinical manifestations in SLE patients.
Main Methods:
- Sera from SLE patients and patients with other systemic rheumatic diseases were analyzed for autoantibodies to ASE-1.
- The frequency and epitope recognition patterns of ASE-1 autoantibodies were assessed.
- Associations between ASE-1 reactivity and clinical features, including serositis and renal involvement, were examined.
Main Results:
- Autoantibodies to ASE-1 were found at a higher frequency in SLE sera compared to other rheumatic diseases.
- ASE-1 autoantibody specificity for SLE increased with the number of recognized epitopes.
- ASE-1 reactivity was associated with a history of serositis, unlike anti-dsDNA antibodies which are linked to renal involvement.
Conclusions:
- ASE-1 autoantibodies are a potential serum marker for SLE, particularly associated with serositis.
- ASE-1 should be considered among the key autoantigens relevant to the serological profile of SLE.